Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.9 USD | -2.84% | -3.24% | -7.18% |
Financials (USD)
Sales 2024 * | 638M | Sales 2025 * | 740M | Capitalization | 9.33B |
---|---|---|---|---|---|
Net income 2024 * | 45M | Net income 2025 * | 88M | EV / Sales 2024 * | 14.2 x |
Net cash position 2024 * | 284M | Net cash position 2025 * | 420M | EV / Sales 2025 * | 12 x |
P/E ratio 2024 * |
286
x | P/E ratio 2025 * |
112
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.42% |
Latest transcript on Repligen Corporation
1 day | -2.84% | ||
1 week | -3.24% | ||
Current month | +1.64% | ||
1 month | +6.21% | ||
3 months | -14.02% | ||
6 months | +6.30% | ||
Current year | -7.18% |
Managers | Title | Age | Since |
---|---|---|---|
Tony Hunt
CEO | Chief Executive Officer | 60 | 14-04-30 |
Olivier Loeillot
PSD | President | 54 | 23-10-01 |
Jason Garland
DFI | Director of Finance/CFO | 50 | 23-09-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
CHM | Chairman | 72 | 05-08-31 |
Director/Board Member | 58 | 14-06-11 | |
Martin Madaus
BRD | Director/Board Member | 64 | 23-02-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.43% | 5 M€ | -1.80% | - | |
1.01% | 0 M€ | 0.00% | - | |
0.84% | 0 M€ | 0.00% | - | |
0.55% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 166.9 | -2.84% | 358,952 |
24-05-20 | 171.8 | -0.09% | 319,889 |
24-05-17 | 171.9 | +0.53% | 456,301 |
24-05-16 | 171 | -2.84% | 430,952 |
24-05-15 | 176 | +2.06% | 467,344 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.18% | 9.33B | |
-6.46% | 179B | |
+3.39% | 113B | |
-3.68% | 67.88B | |
+5.44% | 52.03B | |
+5.70% | 43.3B | |
+4.03% | 41.79B | |
+25.42% | 32.49B | |
+14.00% | 25.65B | |
-4.29% | 24.55B |
- Stock Market
- Equities
- RGEN Stock